(NASDAQ: MRUS) Merus Nv's forecast annual revenue growth rate of 17.35% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.23%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.33%.
Merus Nv's revenue in 2025 is $67,889,000.On average, 5 Wall Street analysts forecast MRUS's revenue for 2025 to be $3,787,782,160, with the lowest MRUS revenue forecast at $3,501,514,810, and the highest MRUS revenue forecast at $4,246,252,888. On average, 6 Wall Street analysts forecast MRUS's revenue for 2026 to be $2,968,085,780, with the lowest MRUS revenue forecast at $332,225,165, and the highest MRUS revenue forecast at $4,804,806,446.
In 2027, MRUS is forecast to generate $8,849,094,119 in revenue, with the lowest revenue forecast at $1,339,282,696 and the highest revenue forecast at $15,391,022,895.